Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Main Authors: | Viktoriya Borisovna Mychka, Irina Evgen'evna Chazova, V B Mychka, I E Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2009-03-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/view/33071 |
Similar Items
-
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
by: E Evgen'evna Chazova, et al.
Published: (2015-06-01) -
Metabolic syndrome
by: Viktoriya Borisovna Mychka, et al.
Published: (2009-03-01) -
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
by: Irina Evgen'evna Chazova, et al.
Published: (2009-12-01) -
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)
by: Viktoriya Borisovna Mychka, et al.
Published: (2009-12-01) -
Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01)